APO RESEARCH · REPORT
Gaprin
Gaprin is a full-fledged microbiological protein, which is a biomass of inactivated cells of non-pathogenic methanotrophic bacteria and is intended for use as the main functional component of compound feeds and protein-vitamin supplements (BVD). Thanks to it, it is possible to produce complete, balanced compound feeds that ensure the intensive development of animal husbandry, poultry and fish farming. Gaprin contains: crude protein 70-79%. According to its composition, gaprin is a complete protein product with a high content of B vitamins (especially B12), amino acids and microelements, which fully meets the needs of animals of various groups and ages. In addition, in comparison with protein feeds of plant origin (including cereals and legumes, including soybeans), gaprin provides balanced amino acid nutrition for animals, primarily in terms of lysine, serine and methionine. Gaprin was produced from 1985 to 1994 at a pilot plant at the Svetlo-Yarsk BVK plant in the Volgograd region of CIS. Of the 40 thousand tons of haprin produced during the specified period, most of it was exported. However, in 1994 this production was closed. The bioprotein gaprin can also be produced from associated petroleum gas (APG), which is still flared in refineries and oil fields, including offshore oil platforms, as well as from methane from mines, coal seams and from methane biogas from waste processing.
Product & engineering
Understand the product.
Gaprin is a full-fledged microbiological protein, which is a biomass of inactivated cells of non-pathogenic methanotrophic bacteria and is intended for use as the main functional component of compound feeds and protein-vitamin supplements (BVD). Thanks to it, it is possible to produce complete, balanced compound feeds that ensure the intensive development of animal husbandry, poultry and fish farming. Gaprin contains: crude protein 70-79%. According to its composition, gaprin is a complete protein product with a high content of B vitamins (especially B12), amino acids and microelements, which fully meets the needs of animals of various groups and ages. In addition, in comparison with protein feeds of plant origin (including cereals and legumes, including soybeans), gaprin provides balanced amino acid nutrition for animals, primarily in terms of lysine, serine and methionine. Gaprin was produced from 1985 to 1994 at a pilot plant at the Svetlo-Yarsk BVK plant in the Volgograd region of CIS. Of the 40 thousand tons of haprin produced during the specified period, most of it was exported. However, in 1994 this production was closed. The bioprotein gaprin can also be produced from associated petroleum gas (APG), which is still flared in refineries and oil fields, including offshore oil platforms, as well as from methane from mines, coal seams and from methane biogas from waste processing.
Selected research
Market Analysis & Forecast
Global Gaprin Market Analysis and Forecast 2026-2032
Market perspective
Gaprin is a full-fledged microbiological protein, which is a biomass of inactivated cells of non-pathogenic methanotrophic bacteria and is intended for use as the main functional component of compound feeds and protein-vitamin supplements (BVD). Thanks to it, it is possible to produce complete, balanced compound feeds that ensure the intensive development of animal husbandry, poultry and fish farming. Gaprin contains: crude protein 70-79%. According to its composition, gaprin is a complete protein product with a high content of B vitamins (especially B12), amino acids and microelements, which fully meets the needs of animals of various groups and ages. In addition, in comparison with protein feeds of plant origin (including cereals and legumes, including soybeans), gaprin provides balanced amino acid nutrition for animals, primarily in terms of lysine, serine and methionine. Gaprin was produced from 1985 to 1994 at a pilot plant at the Svetlo-Yarsk BVK plant in the Volgograd region of CIS. Of the 40 thousand tons of haprin produced during the specified period, most of it was exported. However, in 1994 this production was closed. The bioprotein gaprin can also be produced from associated petroleum gas (APG), which is still flared in refineries and oil fields, including offshore oil platforms, as well as from methane from mines, coal seams and from methane biogas from waste processing.
Global Gaprin key players include Unibio, Calysta, Prtotelux, Metanica, Giprobiosyntez, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest market, with a share about 50%, followed by Europe and North America, both have a share about 38% percent. In terms of product, Feed Grade Gaprin is the largest segment, with a share over 70%. And in terms of Application, the largest level is Animal Feed, followed by Food & Beverages, etc.
This report presents an overview of global market for Gaprin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
Read the full market overview
This report researches the key producers of Gaprin, also provides the sales of main regions and countries. Of the upcoming market potential for Gaprin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gaprin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gaprin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Gaprin sales, projected growth trends, production technology, application and end-user industry.
Gaprin Segment by Company
Unibio
Calysta
Prtotelux
Metanica
Giprobiosyntez
Gaprin Segment by Type
Food Grade Gaprin
Feed Grade Gaprin
Gaprin Segment by Application
Food & Beverages
Animal Feed
Others
Gaprin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gaprin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gaprin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gaprin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Gaprin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Gaprin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gaprin sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Food Grade Gaprin
- Feed Grade Gaprin
Applications
- Food & Beverages
- Animal Feed
- Others
Companies covered
- Unibio
- Calysta
- Prtotelux
- Metanica
- Giprobiosyntez
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Gaprin Market by Type
- 1.2.1 Global Gaprin Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Food Grade Gaprin
- 1.2.3 Feed Grade Gaprin
- 1.3 Gaprin Market by Application
- 1.3.1 Global Gaprin Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Food & Beverages
- 1.3.3 Animal Feed
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Gaprin Market Dynamics
- 2.1 Gaprin Industry Trends
- 2.2 Gaprin Industry Drivers
- 2.3 Gaprin Industry Opportunities and Challenges
- 2.4 Gaprin Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Gaprin Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Gaprin Revenue by Region
- 3.2.1 Global Gaprin Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Gaprin Revenue by Region (2021-2026)
- 3.2.3 Global Gaprin Revenue by Region (2027-2032)
- 3.2.4 Global Gaprin Revenue Market Share by Region (2021-2032)
- 3.3 Global Gaprin Sales Estimates and Forecasts 2021-2032
- 3.4 Global Gaprin Sales by Region
- 3.4.1 Global Gaprin Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Gaprin Sales by Region (2021-2026)
- 3.4.3 Global Gaprin Sales by Region (2027-2032)
- 3.4.4 Global Gaprin Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Gaprin Revenue by Manufacturers
- 4.1.1 Global Gaprin Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Gaprin Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Gaprin Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Gaprin Sales by Manufacturers
- 4.2.1 Global Gaprin Sales by Manufacturers (2021-2026)
- 4.2.2 Global Gaprin Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Gaprin Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Gaprin Sales Price by Manufacturers (2021-2026)
- 4.4 Global Gaprin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Gaprin Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Gaprin Manufacturers, Product Type & Application
- 4.7 Global Gaprin Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Gaprin Market CR5 and HHI
- 4.8.2 2025 Gaprin Tier 1, Tier 2, and Tier 3
5 Gaprin Market by Type
- 5.1 Global Gaprin Revenue by Type
- 5.1.1 Global Gaprin Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Gaprin Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Gaprin Revenue Market Share by Type (2021-2032)
- 5.2 Global Gaprin Sales by Type
- 5.2.1 Global Gaprin Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Gaprin Sales by Type (2021-2032) & (K Ton)
- 5.2.3 Global Gaprin Sales Market Share by Type (2021-2032)
- 5.3 Global Gaprin Price by Type
6 Gaprin Market by Application
- 6.1 Global Gaprin Revenue by Application
- 6.1.1 Global Gaprin Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Gaprin Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Gaprin Revenue Market Share by Application (2021-2032)
- 6.2 Global Gaprin Sales by Application
- 6.2.1 Global Gaprin Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Gaprin Sales by Application (2021-2032) & (K Ton)
- 6.2.3 Global Gaprin Sales Market Share by Application (2021-2032)
- 6.3 Global Gaprin Price by Application
7 Company Profiles
- 7.1 Unibio
- 7.1.1 Unibio Company Information
- 7.1.2 Unibio Business Overview
- 7.1.3 Unibio Gaprin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Unibio Gaprin Product Portfolio
- 7.1.5 Unibio Recent Developments
- 7.2 Calysta
- 7.2.1 Calysta Company Information
- 7.2.2 Calysta Business Overview
- 7.2.3 Calysta Gaprin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Calysta Gaprin Product Portfolio
- 7.2.5 Calysta Recent Developments
- 7.3 Prtotelux
- 7.3.1 Prtotelux Company Information
- 7.3.2 Prtotelux Business Overview
- 7.3.3 Prtotelux Gaprin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Prtotelux Gaprin Product Portfolio
- 7.3.5 Prtotelux Recent Developments
- 7.4 Metanica
- 7.4.1 Metanica Company Information
- 7.4.2 Metanica Business Overview
- 7.4.3 Metanica Gaprin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Metanica Gaprin Product Portfolio
- 7.4.5 Metanica Recent Developments
- 7.5 Giprobiosyntez
- 7.5.1 Giprobiosyntez Company Information
- 7.5.2 Giprobiosyntez Business Overview
- 7.5.3 Giprobiosyntez Gaprin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Giprobiosyntez Gaprin Product Portfolio
- 7.5.5 Giprobiosyntez Recent Developments
8 North America
- 8.1 North America Gaprin Market Size by Type
- 8.1.1 North America Gaprin Revenue by Type (2021-2032)
- 8.1.2 North America Gaprin Sales by Type (2021-2032)
- 8.1.3 North America Gaprin Price by Type (2021-2032)
- 8.2 North America Gaprin Market Size by Application
- 8.2.1 North America Gaprin Revenue by Application (2021-2032)
- 8.2.2 North America Gaprin Sales by Application (2021-2032)
- 8.2.3 North America Gaprin Price by Application (2021-2032)
- 8.3 North America Gaprin Market Size by Country
- 8.3.1 North America Gaprin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Gaprin Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Gaprin Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Gaprin Market Size by Type
- 9.1.1 Europe Gaprin Revenue by Type (2021-2032)
- 9.1.2 Europe Gaprin Sales by Type (2021-2032)
- 9.1.3 Europe Gaprin Price by Type (2021-2032)
- 9.2 Europe Gaprin Market Size by Application
- 9.2.1 Europe Gaprin Revenue by Application (2021-2032)
- 9.2.2 Europe Gaprin Sales by Application (2021-2032)
- 9.2.3 Europe Gaprin Price by Application (2021-2032)
- 9.3 Europe Gaprin Market Size by Country
- 9.3.1 Europe Gaprin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Gaprin Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Gaprin Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Gaprin Market Size by Type
- 10.1.1 China Gaprin Revenue by Type (2021-2032)
- 10.1.2 China Gaprin Sales by Type (2021-2032)
- 10.1.3 China Gaprin Price by Type (2021-2032)
- 10.2 China Gaprin Market Size by Application
- 10.2.1 China Gaprin Revenue by Application (2021-2032)
- 10.2.2 China Gaprin Sales by Application (2021-2032)
- 10.2.3 China Gaprin Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Gaprin Market Size by Type
- 11.1.1 Asia Gaprin Revenue by Type (2021-2032)
- 11.1.2 Asia Gaprin Sales by Type (2021-2032)
- 11.1.3 Asia Gaprin Price by Type (2021-2032)
- 11.2 Asia Gaprin Market Size by Application
- 11.2.1 Asia Gaprin Revenue by Application (2021-2032)
- 11.2.2 Asia Gaprin Sales by Application (2021-2032)
- 11.2.3 Asia Gaprin Price by Application (2021-2032)
- 11.3 Asia Gaprin Market Size by Country
- 11.3.1 Asia Gaprin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Gaprin Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Gaprin Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Gaprin Market Size by Type
- 12.1.1 SAMEA Gaprin Revenue by Type (2021-2032)
- 12.1.2 SAMEA Gaprin Sales by Type (2021-2032)
- 12.1.3 SAMEA Gaprin Price by Type (2021-2032)
- 12.2 SAMEA Gaprin Market Size by Application
- 12.2.1 SAMEA Gaprin Revenue by Application (2021-2032)
- 12.2.2 SAMEA Gaprin Sales by Application (2021-2032)
- 12.2.3 SAMEA Gaprin Price by Application (2021-2032)
- 12.3 SAMEA Gaprin Market Size by Country
- 12.3.1 SAMEA Gaprin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Gaprin Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Gaprin Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Gaprin Value Chain Analysis
- 13.1.1 Gaprin Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Gaprin Production Mode & Process
- 13.2 Gaprin Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Gaprin Distributors
- 13.2.3 Gaprin Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst